Laurion Capital Management LP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$131,890
-55.7%
30,530
-1.2%
0.00%
-75.0%
Q3 2020$298,000
+22.6%
30,900
+108.8%
0.00%
+100.0%
Q4 2019$243,000
-46.4%
14,800
-56.6%
0.00%
-33.3%
Q3 2019$453,000
+19.2%
34,100
+26.5%
0.00%
-25.0%
Q2 2019$380,000
-75.0%
26,955
-59.2%
0.00%
-73.3%
Q3 2018$1,518,000
-53.6%
66,111
-65.9%
0.02%
-42.3%
Q1 2018$3,270,000194,0700.03%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders